Exact Mass: 552.2736
Exact Mass Matches: 552.2736
Found 500 metabolites which its exact mass value is equals to given mass value 552.2736
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bipindogulomethyloside
Bipindogulomethyloside is isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the US Isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.
Handelin
Handelin is a sesterterpenoid. [(1R,2R,3R,3aR,4S,5S,6R,6aR,9S,9aR,9bR,10S,11R)-2,6-dihydroxy-2,6,9,11-tetramethyl-6-methylidene-2,7-dioxospiro[4,5,6a,7,9a,9b-hexahydro-3aH-azuleno[4,5-b]furan-3,15-8-oxatetracyclo[9.2.2.01,10.05,9]pentadec-12-ene]-4-yl] acetate is a natural product found in Tanacetum vulgare, Chrysanthemum lavandulifolium, and other organisms with data available. Handelin is a guaianolide dimer from Chrysanthemum boreale that has potent anti-inflammatory activity by down-regulating NF-κB signaling and pro-inflammatory cytokine production[1]. Handelin is a guaianolide dimer from Chrysanthemum boreale that has potent anti-inflammatory activity by down-regulating NF-κB signaling and pro-inflammatory cytokine production[1].
lokundjoside
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
Desglucocheirotoxol
Convallatoxol is isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA. Isolated from Convallaria majalis. Convallaria majalis is banned by the FDA from food use in the USA.
D-Phenylalanyl-L-2-piperidinecarbonyl-N-(4-nitro phenyl)-L-argininamide
PA(2:0/PGF1alpha)
PA(2:0/PGF1alpha) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/PGF1alpha), in particular, consists of one chain of one acetyl at the C-1 position and one chain of Prostaglandin F1alpha at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(PGF1alpha/2:0)
PA(PGF1alpha/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(PGF1alpha/2:0), in particular, consists of one chain of one Prostaglandin F1alpha at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Euhorbiasteroid
Euphorbiasteroid is a natural product found in Macaranga tanarius and Euphorbia lathyris with data available.
EFL1 diterpene
Bipindogulomethyloside
3-[(3R,5S,10R,13R,14S,17R)-5,14-dihydroxy-10,13-dimethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
sarmentogenin-3-O-beta-D-allopyranoside|sarmentogenin-3beta-O-(beta-D-alloside)|sarmentogenin-3beta-O-
11-O-trans-Cinnamoyl-12-O-acetyl-17alphaH-marsdenin
(5R*,7S*,8S*,9S*,10R*)-1-beta-D-glucopyranosyl-7alpha-acetoxycleroda-3,13-dien-16,15-olide-18-oate
16beta-hydroxy-heteroclitalactone H|heteroclitalactone I
(5R*,7S*,8S*,9S*,10R*)-1-beta-D-glucopyranosyl-7alpha-acetoxycleroda-3,13-dien-15,16-olide-18-oate
2-O-pentadecanoyl-2-hydroxy-8-methoxy-6,7-methylenedioxyisoflavone|aervin D
3,4,5-trihydroxydrhydro-alpha-ionol-9-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
Glu Tyr Asn Lys
C29H44O10_Card-20(22)-enolide, 3-(beta-D-glucopyranosyloxy)-5,14-dihydroxy-, (3alpha,5beta,8xi,9xi)
Cys Phe Lys Arg
Cys Phe Gln Arg
Cys Phe Arg Lys
Cys Phe Arg Gln
Cys Lys Phe Arg
Cys Lys Arg Phe
Cys Gln Phe Arg
Cys Gln Arg Phe
Cys Arg Phe Lys
Cys Arg Phe Gln
Cys Arg Lys Phe
Cys Arg Gln Phe
Asp Lys Lys Tyr
Asp Lys Gln Tyr
Asp Lys Tyr Lys
Asp Lys Tyr Gln
Asp Gln Lys Tyr
Asp Gln Tyr Lys
Asp Tyr Lys Lys
Asp Tyr Lys Gln
Asp Tyr Gln Lys
Glu Lys Asn Tyr
Glu Lys Tyr Asn
Glu Asn Lys Tyr
Glu Asn Tyr Lys
Glu Tyr Lys Asn
Phe Cys Lys Arg
Phe Cys Gln Arg
Phe Cys Arg Lys
Phe Cys Arg Gln
Phe His His Ile
Phe His His Leu
Phe His Ile His
Phe His Leu His
Phe Ile His His
Phe Lys Cys Arg
Phe Lys Met Gln
Phe Lys Gln Met
Phe Lys Arg Cys
Phe Leu His His
Phe Met Lys Gln
Phe Met Gln Lys
Phe Gln Cys Arg
Phe Gln Lys Met
Phe Gln Met Lys
Phe Gln Arg Cys
Phe Arg Cys Lys
Phe Arg Cys Gln
Phe Arg Lys Cys
Phe Arg Gln Cys
Gly Lys Trp Tyr
Gly Lys Tyr Trp
Gly Trp Lys Tyr
Gly Trp Tyr Lys
Gly Tyr Lys Trp
Gly Tyr Trp Lys
His Phe His Ile
His Phe His Leu
His Phe Ile His
His Phe Leu His
His His Phe Ile
His His Phe Leu
His His Ile Phe
His His Leu Phe
His Ile Phe His
His Ile His Phe
His Leu Phe His
His Leu His Phe
Ile Phe His His
Ile His Phe His
Ile His His Phe
Lys Cys Phe Arg
Lys Cys Arg Phe
Lys Asp Lys Tyr
Lys Asp Gln Tyr
Lys Asp Tyr Lys
Lys Asp Tyr Gln
Lys Glu Asn Tyr
Lys Glu Tyr Asn
Lys Phe Cys Arg
Lys Phe Met Gln
Lys Phe Gln Met
Lys Phe Arg Cys
Lys Gly Trp Tyr
Lys Gly Tyr Trp
Lys Lys Asp Tyr
Lys Lys Tyr Asp
Lys Met Phe Gln
Lys Met Gln Phe
Lys Asn Glu Tyr
Lys Asn Tyr Glu
Lys Gln Asp Tyr
Lys Gln Phe Met
Lys Gln Met Phe
Lys Gln Tyr Asp
Lys Arg Cys Phe
Lys Arg Phe Cys
Lys Trp Gly Tyr
Lys Trp Tyr Gly
Lys Tyr Asp Lys
Lys Tyr Asp Gln
Lys Tyr Glu Asn
Lys Tyr Gly Trp
Lys Tyr Lys Asp
Lys Tyr Asn Glu
Lys Tyr Gln Asp
Lys Tyr Trp Gly
Leu Phe His His
Leu His Phe His
Leu His His Phe
Met Phe Lys Gln
Met Phe Gln Lys
Met Lys Phe Gln
Met Lys Gln Phe
Met Gln Phe Lys
Met Gln Lys Phe
Asn Glu Lys Tyr
Asn Glu Tyr Lys
Asn Lys Glu Tyr
Asn Lys Tyr Glu
Asn Arg Thr Tyr
Asn Arg Tyr Thr
Asn Thr Arg Tyr
Asn Thr Tyr Arg
Asn Tyr Glu Lys
Asn Tyr Lys Glu
Asn Tyr Arg Thr
Asn Tyr Thr Arg
Gln Cys Phe Arg
Gln Cys Arg Phe
Gln Asp Lys Tyr
Gln Asp Tyr Lys
Gln Phe Cys Arg
Gln Phe Lys Met
Gln Phe Met Lys
Gln Lys Asp Tyr
Gln Lys Phe Met
Gln Lys Met Phe
Gln Lys Tyr Asp
Gln Met Phe Lys
Gln Met Lys Phe
Gln Arg Ser Tyr
Gln Arg Tyr Ser
Gln Ser Arg Tyr
Gln Ser Tyr Arg
Gln Tyr Asp Lys
Gln Tyr Lys Asp
Gln Tyr Arg Ser
Gln Tyr Ser Arg
Arg Cys Phe Lys
Arg Cys Lys Phe
Arg Phe Cys Lys
Arg Phe Lys Cys
Arg Lys Cys Phe
Arg Lys Phe Cys
Arg Asn Thr Tyr
Arg Asn Tyr Thr
Arg Gln Ser Tyr
Arg Gln Tyr Ser
Arg Ser Gln Tyr
Arg Ser Tyr Gln
Arg Thr Asn Tyr
Arg Thr Tyr Asn
Arg Tyr Asn Thr
Arg Tyr Gln Ser
Arg Tyr Ser Gln
Arg Tyr Thr Asn
Ser Gln Arg Tyr
Ser Gln Tyr Arg
Ser Arg Gln Tyr
Ser Arg Tyr Gln
Ser Tyr Gln Arg
Ser Tyr Arg Gln
Thr Asn Arg Tyr
Thr Asn Tyr Arg
Thr Arg Asn Tyr
Thr Arg Tyr Asn
Thr Tyr Asn Arg
Thr Tyr Arg Asn
Trp Gly Lys Tyr
Trp Gly Tyr Lys
Trp Lys Gly Tyr
Trp Lys Tyr Gly
Trp Tyr Gly Lys
Trp Tyr Lys Gly
Tyr Asp Lys Lys
Tyr Asp Lys Gln
Tyr Asp Gln Lys
Tyr Glu Lys Asn
Tyr Glu Asn Lys
Tyr Gly Lys Trp
Tyr Gly Trp Lys
Tyr Lys Asp Lys
Tyr Lys Asp Gln
Tyr Lys Glu Asn
Tyr Lys Gly Trp
Tyr Lys Lys Asp
Tyr Lys Asn Glu
Tyr Lys Gln Asp
Tyr Lys Trp Gly
Tyr Asn Glu Lys
Tyr Asn Lys Glu
Tyr Asn Arg Thr
Tyr Asn Thr Arg
Tyr Gln Asp Lys
Tyr Gln Lys Asp
Tyr Gln Arg Ser
Tyr Gln Ser Arg
Tyr Arg Asn Thr
Tyr Arg Gln Ser
Tyr Arg Ser Gln
Tyr Arg Thr Asn
Tyr Ser Gln Arg
Tyr Ser Arg Gln
Tyr Thr Asn Arg
Tyr Thr Arg Asn
Tyr Trp Gly Lys
Tyr Trp Lys Gly
Deglucocheirotoxol
Cuspidoside
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides
Emetine hydrochloride
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D005765 - Gastrointestinal Agents > D002400 - Cathartics D005765 - Gastrointestinal Agents > D004639 - Emetics D002491 - Central Nervous System Agents C784 - Protein Synthesis Inhibitor
LEE011 succinate
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(2R,3S,4S,5S)-5-HYDROXY-2,3,4-TRIS(PHENYLMETHOXY)-5-[(PHENYLMETHOXY)METHYL]-CYCLOHEXANONE
1,1-Hexadecane-1,16-diylbis(1-methylpyrrolidinium) dibromide
14,15-Dihydroajugapitin
A diterpenoid isolated from the aerial parts of Ajuga bracteosa.
3-[(21S,22S)-11-ethyl-4-hydroxy-16-[(1R)-1-hydroxyethyl]-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
15-hydroxyajubractin C
A diterpenoid isolated from the aerial parts of Ajuga bracteosa.
3-(1,3-benzodioxol-5-yl)-1-[[(2R,3S)-8-(3-hydroxyhex-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
N-[(2S,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[(2R,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[(2R,3R)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
N-[(2S,3S)-2-[[[(1,3-benzodioxol-5-ylamino)-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]cyclopropanecarboxamide
[1-acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
[1-[(E)-dec-4-enoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
[1-[(4E,7E)-deca-4,7-dienoyl]oxy-3-phosphonooxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
(2'r,5r,6s,9's,9bs)-2',6-dihydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7'-dioxo-4,5,6a,7,9a,9b-hexahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-5-yl acetate
4-(3a,5a-dihydroxy-9a,11a-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl)-5h-furan-2-one
(1r,2r)-1-(3,4-dimethoxyphenyl)-2-{4-[(2s,3r,4r,5s)-5-(3,4-dimethoxyphenyl)-3,4-dimethyloxolan-2-yl]-3-methoxyphenoxy}propan-1-ol
(6-{[4-(1,4-dihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
4-[(1r,3as,3bs,5ar,7s,9ar,9bs,10r,11ar)-3a,10-dihydroxy-9a-(hydroxymethyl)-11a-methyl-7-{[(2r,3r,4r,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one
(2e,4e,6r)-n-[(3r,4s)-3,4-dihydroxy-3-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-6-oxocyclohex-1-en-1-yl]-2,4,6-trimethyldeca-2,4-dienimidic acid
(1r,2s,3e,5s,7s,8e,10r,13s)-5,9,10-tris(acetyloxy)-2,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-13-yl acetate
(1'r,2r,3'e,5'r,7's,11's,12'r,13's,14's)-1',11'-bis(acetyloxy)-3',6',6',14'-tetramethyl-2'-oxospiro[oxirane-2,10'-tricyclo[10.3.0.0⁵,⁷]pentadecan]-3'-en-13'-yl 2-phenylacetate
(1r,2r,3s,4r,5r,7s,8s,9s,12z,14s,17r)-7,9-bis(acetyloxy)-2,4-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-5-yl butanoate
(4e,7s)-n-[(2z,4z)-2-(chloromethylidene)-4-methoxy-6-(4-methoxy-2-oxo-5h-pyrrol-1-yl)-6-oxohex-4-en-1-yl]-7-methoxy-n-methyltetradec-4-enamide
(2s,3r,4r,5r,6r)-2-methyl-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r,3e)-4-[(1s,2s,4s)-1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxan-2-yl]methoxy}oxane-3,4,5-triol
(1s,3r,5s,6s,15r,18e,21s,23s)-5,10-dihydroxy-6,12,17,17,21,27-hexamethyl-7,22,24,28-tetraoxahexacyclo[21.4.3.0¹,²³.0³,²¹.0⁶,¹⁵.0⁸,¹³]triaconta-8,10,12,18,26-pentaene-25,29-dione
(1r,2s,3r,4ar,5s,6r,8s,8ar)-5-[(2s,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-8-(acetyloxy)-8a-[(acetyloxy)methyl]-3-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-2-yl (2s)-2-methylbutanoate
ethyl 4-[(1s,7s,13r,15r)-3-hydroxy-5-oxo-7-phenyl-13-[(1e)-2-phenylethenyl]-8,14-dioxatetracyclo[11.3.1.0²,¹¹.0⁴,⁹]heptadeca-2,4(9),10-trien-15-yl]butanoate
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 7-(acetyloxy)-5,6,8a-trimethyl-5-[2-(2-oxo-5h-furan-3-yl)ethyl]-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylate
4-[3a,11-dihydroxy-9a-(hydroxymethyl)-11a-methyl-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-tetradecahydrocyclopenta[a]phenanthren-1-yl]-5h-furan-2-one
17-hydroxy-12-methyl-7-oxo-17-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-8-oxapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-5-en-18-yl acetate
4-[(1r,3as,3bs,5as,7r,9ar,9br,10r,11ar)-3a,5a,10-trihydroxy-9a,11a-dimethyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5h-furan-2-one
(1's,2s,2's,4'r,9's,11'e,15'r)-2',20'-dihydroxy-1',3,9',13',13',18'-hexamethyl-5-oxo-8',23'-dioxaspiro[furan-2,6'-tetracyclo[13.8.0.0⁴,⁹.0¹⁷,²²]tricosane]-11',17',19',21'-tetraen-7'-ylideneacetic acid
(1s,2s,3e,5r,7s,8z,10r,13s)-2,9,10-tris(acetyloxy)-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethylbicyclo[9.3.1]pentadeca-3,8,11-trien-13-yl acetate
4,15-dimethoxy-2,6,14,17-tetramethyl-11-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-4,14-diene-3,16-dione
(1s,2r,3s,4s,5r,7s,8s,9r,12z,14s,17r)-2,7-bis(acetyloxy)-4,5-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-9-yl butanoate
8-(acetyloxy)-8a-[(acetyloxy)methyl]-5-{hexahydrofuro[2,3-b]furan-2-yl}-2-hydroxy-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-4-yl 2-methylbutanoate
13-(chloromethyl)-2,3,9-trihydroxy-4,6a,11,11,14b-pentamethyl-2,3,4a,5,6,7,8,9,10,12,12a,13,14,14a-tetradecahydro-1h-picene-4,8a-dicarboxylic acid
2-{[5,7-dihydroxy-2,2-dimethyl-6-(2-methylpropanoyl)chromen-8-yl]methyl}-3,5-dihydroxy-4-methyl-4-(3-methylbut-2-en-1-yl)-6-(2-methylpropanoyl)cyclohexa-2,5-dien-1-one
4-{[5,7-dihydroxy-2,2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methyl}-3,5-dihydroxy-6-methyl-6-(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one
(2r,3z,5s,7s,8e,10s,11r,13s)-2,3,10-tris(acetyloxy)-7,13-dihydroxy-8-(hydroxymethyl)-4,14,15,15-tetramethylbicyclo[9.3.1]pentadeca-1(14),3,8-trien-5-yl acetate
(9r,13s,15s,16r,17r,18s)-15-hydroxy-16-[(1r)-1-hydroxy-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-8,8,13,17-tetramethyl-6-oxo-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4,10-tetraen-18-yl acetate
1-(3,4-dimethoxyphenyl)-2-{4-[5-(3,4-dimethoxyphenyl)-3,4-dimethyloxolan-2-yl]-2-methoxyphenoxy}propan-1-ol
13-deacetylcanadensene
{"Ingredient_id": "HBIN001161","Ingredient_name": "13-deacetylcanadensene","Alias": "NA","Ingredient_formula": "C28H40O11","Ingredient_Smile": "CC1=C2C(C(=C(C(CC(C(=CC(C(C2(C)C)CC1O)OC(=O)C)CO)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4734","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
19-hydroxy-sarmentogenin-3β-o-β-6-deoxygu-loside
{"Ingredient_id": "HBIN002200","Ingredient_name": "19-hydroxy-sarmentogenin-3\u03b2-o-\u03b2-6-deoxygu-loside","Alias": "NA","Ingredient_formula": "C29H44O10","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3C(CC5(C4(CCC5C6=CC(=O)OC6)O)C)O)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3β,5β,11α,14β-tetrahydroxy-5β-card-20(22)eno-lide-3α-l-rhamnoside
{"Ingredient_id": "HBIN008092","Ingredient_name": "3\u03b2,5\u03b2,11\u03b1,14\u03b2-tetrahydroxy-5\u03b2-card-20(22)eno-lide-3\u03b1-l-rhamnoside","Alias": "3beta,5beta,11alpha,14beta-tetrahydroxy-5beta-card-20(22)enolide-3alpha-l-rhamnoside","Ingredient_formula": "C29H44O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21068;32028","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-deacetyltaxachitriene b
{"Ingredient_id": "HBIN011505","Ingredient_name": "5-deacetyltaxachitriene b","Alias": "NA","Ingredient_formula": "C28H40O11","Ingredient_Smile": "CC1=C2C(C(=C(C(CC(C(=CC(C(C2(C)C)CC1OC(=O)C)O)CO)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "552.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4776","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101702748","DrugBank_id": "NA"}
7-Deacetylcanadensene
{"Ingredient_id": "HBIN013143","Ingredient_name": "7-Deacetylcanadensene","Alias": "[(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetoxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] acetate; [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetyloxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] ethanoate; acetic acid [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetoxy-5,7-dihydroxy-8,12,15,15-tetramethyl-4-methylol-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] ester; acetic acid [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetoxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] ester; 7-deacetylcanadensene; [(1R,2S,3E,5S,7S,8Z,10R,13S)-2,9,10-triacetyloxy-5,7-dihydroxy-4-(hydroxymethyl)-8,12,15,15-tetramethyl-13-bicyclo[9.3.1]pentadeca-3,8,11-trienyl] acetate","Ingredient_formula": "C28H40O11","Ingredient_Smile": "CC1=C(C(C2=C(C(CC(C2(C)C)C(C=C(C(CC1O)O)CO)OC(=O)C)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "552.61","OB_score": "7.53251491","CAS_id": "222404-07-1","SymMap_id": "SMIT01201","TCMID_id": "4733","TCMSP_id": "MOL011386","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alliside
{"Ingredient_id": "HBIN015203","Ingredient_name": "alliside","Alias": "NA","Ingredient_formula": "C29H44O10","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "922","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
antiogoside
{"Ingredient_id": "HBIN016377","Ingredient_name": "antiogoside","Alias": "NA","Ingredient_formula": "C29H44O10","Ingredient_Smile": "CC1C(C(C(C(O1)OC2CCC3(C4CC(C5(C(CCC5(C4CCC3(C2)O)O)C6=CC(=O)OC6)C)O)C)O)O)O","Ingredient_weight": "552.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6739;21613","PubChem_id": "21550487","DrugBank_id": "NA"}